GGrantIndex
Sort

64,565 grants matching drug discovery

CHEMISTRY CENTER FOR COMBATING ANTIBIOTIC-RESISTANT BACTERIA (CC4CARB)

$3,218,132
Bruce Blough · Research Triangle Institute · N01 · FY2021 · AI

New Mexico Molecular Libraries Screening Center(RMI)

$3,215,956
Larry A. Sklar · University Of New Mexico · U54 · FY2006 · MH

Collaboration on preclinical autism cellular assays, biosignatures, and network analyses (Copacabana)

$3,214,781
Eugene Wei-Ming Yeo · University Of California, San Diego · U19 · FY2019 · MH

SAN ANTONIO CANCER INSTITUTE

$3,213,782
Cancer Therapy And Research Center · P30 · FY2002 · CA

Genetic and clinical studies of Gaucher disease and other lysosomal disorders

$3,211,711
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2022 · HG

DATA SCIENCE RESEARCH

$3,211,023
Peipei Ping · University Of California Los Angeles · U54 · FY2017 · GM

Advancing novel cyanide countermeasures

$3,209,373
Calum A. Macrae · Brigham And Women'S Hospital · U54 · FY2020 · NS

Medicinal Chemistry and Chemical Biology Core (MCCB)

$3,206,036
Timothy I Richardson · Indiana University Indianapolis · U54 · FY2025 · AG

Measurement of Cancer-Associated Biomarker Proteins in Complex Biological Samples

$3,205,352
Amanda G Paulovich · Fred Hutchinson Cancer Research Center · RC2 · FY2009 · CA

Discovery and validation of novel targets for pharmacotherapy of alcoholism

$3,203,547
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration

$3,199,356
Christopher Ramsden · National Institute On Aging · ZIA · FY2025 · AG

Heartland Institute for Clinical and Translational Research

$3,197,840
Richard J. Barohn · University Of Kansas Medical Center · UL1 · FY2012 · TR

Advancing novel cyanide countermeasures

$3,197,049
Calum A. Macrae · Brigham And Women'S Hospital · U54 · FY2021 · NS

Psychometric Reliability and Validity for Behavioral Metrics of Osteoarthritic Pain in Horses

$3,196,061
Kyle D Allen · University Of Florida · R01 · FY2024 · AR

IGF::OT::IGF - Sequencing Services

$3,195,915
Debbie Nickerson · University Of Washington · N02 · FY2017 · HL

Roles and regulation of tissue resident CD8 T cells during a persistent viral infection

$3,194,992
Elina I Zuniga · University Of California, San Diego · R01 · FY2025 · AI

Advancing Novel Cyanide Countermeasures

$3,193,764
Calum A. Macrae · Brigham And Women'S Hospital · U54 · FY2022 · NS

Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication

$3,192,188
Pamela J Lein · University Of California At Davis · U54 · FY2012 · NS

Heartland Institute for Clinical and Translational Research

$3,191,269
Richard J. Barohn · University Of Kansas Medical Center · UL1 · FY2011 · RR

Antimicrobial Drug Discovery from Coevolved Symbiotic Communities

$3,190,133
David R Andes · University Of Wisconsin-Madison · U19 · FY2016 · AI

Antimicrobial Drug Discovery from Coevolved Symbiotic Communities

$3,190,133
David R Andes · University Of Wisconsin-Madison · U19 · FY2017 · AI

Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck

$3,188,803
Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI

Trans-America Consortium of the Health Care Systems Research Network for the Precision Medicine Initiative Cohort Program

$3,187,405
Christine C Johnson · Henry Ford Health System · OT2 · FY2017 · OD

Integrative genetics of behavior with high throughput technologies

$3,183,826
David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA

Lipids as Modulators of the Response to Vascular Injury

$3,183,518
Garret A Fitzgerald · University Of Pennsylvania · P50 · FY2006 · HL